Postpartum Haemorrhage Initiative
Postpartum Haemorrhage (PPH) is the leading cause of maternal mortality in low-income countries.
The most common cause of PPH is poor contraction of the uterus (uterine atony).
Primary PPH is often defined as the loss of more than 500ml or 1,000ml of blood within the first 24 hours following childbirth. Secondary postpartum bleeding is that which occurs after the first day and up to six weeks after childbirth.
Duration: 2010 - 2018
Funded through Gynuity Health Projects
Project Contact: Rachel Gooden, Project Manager
Components of the Postpartum Haemorrhage Initiative
What we have achieved so far
FIGO's member society survey
In 2016 FIGO conducted a survey of our member societies, to find out about their national guidelines for PPH, and inclusion of key PPH medicines on essential medicines lists (EMLs).
The aim of the survey was also to establish any challenges to implementing evidence-based practice, in order to further support FIGO Member Associations in working towards their maternal health goals.
Responses were received from 69 (53%) FIGO Member Associations, with the following findings:
Read the full results here.
- Maternal mortality: a global tragedy (infographic)
- Misoprostol only recommended dosage chart (English, French, Spanish), quick reference card (English, French, Spanish), gestational wheels (English, French, Spanish)
- FIGO's member society survey
- Prevention and treatment of postpartum haemorrhage in low-resource settings
- Guidelines on Prevention of Post-Partum Haemorrhage with Misoprostol
- Guidelines on Treatment of Post-Partum Haemorrhage with Misoprostol
- Misoprostol for the treatment of postpartum haemorrhage in low resource settings (Joint statement by FIGO and ICM)
- The Global Library of Women’s Medicine (GLOWM): Postpartum haemorrhage
- The Global Library of Women’s Medicine (GLOWM): Safer Motherhood app